Technical Analysis for CLSN - Celsion Corporation

Grade Last Price % Change Price Change
grade B 2.3 0.00% 0.00
CLSN closed unchanged on Friday, January 18, 2019, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical CLSN trend table...

Date Alert Name Type % Chg
Jan 18 New Uptrend Bullish 0.00%
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 Upper Bollinger Band Walk Strength 0.00%
Jan 18 Inside Day Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 Stochastic Sell Signal Bearish 0.00%
Jan 17 Pocket Pivot Bullish Swing Setup 0.00%
Jan 17 Upper Bollinger Band Walk Strength 0.00%

Older signals for CLSN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company develops ThermoDox, a liposomal encapsulation of doxorubicin, which is under Phase III clinical trial for primary liver cancer; under phase II clinical trial for colorectal liver metastasis; and under phase II clinical trial for treatment of recurrent chest wall breast cancer. It has a development, product supply, and commercialization agreement with Yakult Honsha Co. for ThermoDox; and a joint research agreement with Royal Philips Electronics to evaluate the combination of Philips' high intensity focused ultrasound with its ThermoDox to determine the potential of this combination to treat various cancers. The company was founded in 1982 and is based in Lawrenceville, New Jersey.
Is CLSN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.48
52 Week Low 1.35
Average Volume 127,137
200-Day Moving Average 2.4596
50-Day Moving Average 1.8865
20-Day Moving Average 1.7588
10-Day Moving Average 1.9895
Average True Range 0.1634
ADX 26.03
+DI 34.3967
-DI 12.0308
Chandelier Exit (Long, 3 ATRs ) 1.9298
Chandelier Exit (Short, 3 ATRs ) 1.8402
Upper Bollinger Band 2.3175
Lower Bollinger Band 1.2001
Percent B (%b) 0.98
BandWidth 63.531954
MACD Line 0.0935
MACD Signal Line 0.0105
MACD Histogram 0.083
Fundamentals Value
Market Cap 19.21 Million
Num Shares 8.35 Million
EPS -5.58
Price-to-Earnings (P/E) Ratio -0.41
Price-to-Sales 47.77
Price-to-Book 2.54
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.42
Resistance 3 (R3) 2.43 2.39 2.40
Resistance 2 (R2) 2.39 2.36 2.39 2.39
Resistance 1 (R1) 2.35 2.34 2.33 2.34 2.39
Pivot Point 2.31 2.31 2.31 2.31 2.31
Support 1 (S1) 2.27 2.28 2.25 2.26 2.21
Support 2 (S2) 2.23 2.26 2.23 2.21
Support 3 (S3) 2.19 2.23 2.20
Support 4 (S4) 2.18